Similar articles

• [Expert opinion on APAP (prolonged action atypical antipsychotic agents). Position of Canadian psychiatry].

  Stip E. Stip E. Encephale. 2009 Jan;Suppl 3:S115-8. doi: 10.1016/S0013-7006(09)75547-2. Encephale. 2009. PMID: 19268180 French. No abstract available.
• [Expert opinion on APAP (prolonged action atypical antipsychotic agents). What are the limiting factors in resort to an APAP and how to overcome them].

  Canceil O, Limosin F, Passerieux C. Canceil O, et al. Encephale. 2009 Jan;Suppl 3:S101-7. doi: 10.1016/S0013-7006(09)75545-9. Encephale. 2009. PMID: 19268178 French. No abstract available.
• [Expert opinion on APAP (prolonged action atypical antipsychotic agents). How to prescribe an APAP?].

  Dassa D, Lacambre M, Vacheron MN. Dassa D, et al. Encephale. 2009 Jan;Suppl 3:S109-13. doi: 10.1016/S0013-7006(09)75546-0. Encephale. 2009. PMID: 19268179 French. No abstract available.
• [Expert opinion on APAP (prolonged action atypical antipsychotic agents). Current status of recommendations for treatment with an APAP].

  Buis C, Gourion D, Vaiva G. Buis C, et al. Encephale. 2009 Jan;Suppl 3:S91-5. doi: 10.1016/S0013-7006(09)75543-5. Encephale. 2009. PMID: 19268185 French. No abstract available.
• [Expert opinion on APAP (prolonged action atypical antipsychotic agents). How to make the decision to resort to an APAP)].

  Chéreau I, Gorwood P, Mouchabac S. Chéreau I, et al. Encephale. 2009 Jan;Suppl 3:S97-100. doi: 10.1016/S0013-7006(09)75544-7. Encephale. 2009. PMID: 19268186 French. No abstract available.